Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis

Objectives: In recent years, commercial molecular tools for diagnosis of invasive aspergillosis have emerged, requiring evaluation to ensure quality. Here we assessed the specificity of Aspergillus spp.-ELITe MGB Assay a commercial assay tergeting 18S gene of Aspergillus spp. Design and methods: As...

Full description

Bibliographic Details
Main Authors: Violaine Bothy, Maria A. Argudín, Nathalie Olive, Cindy Barbée, Benoît Kabamba-Mukadi, Hector Rodriguez-Villalobos
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Practical Laboratory Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551724000246
_version_ 1797291787543379968
author Violaine Bothy
Maria A. Argudín
Nathalie Olive
Cindy Barbée
Benoît Kabamba-Mukadi
Hector Rodriguez-Villalobos
author_facet Violaine Bothy
Maria A. Argudín
Nathalie Olive
Cindy Barbée
Benoît Kabamba-Mukadi
Hector Rodriguez-Villalobos
author_sort Violaine Bothy
collection DOAJ
description Objectives: In recent years, commercial molecular tools for diagnosis of invasive aspergillosis have emerged, requiring evaluation to ensure quality. Here we assessed the specificity of Aspergillus spp.-ELITe MGB Assay a commercial assay tergeting 18S gene of Aspergillus spp. Design and methods: As part of a method validation, we evaluate the specificity of the Aspergillus spp.-ELITe MGB Assay by testing fourteen culture based samples of sequenced non-Aspergillus fungal species. The benefits of a pre-lysis treatment was evaluated in parallel on serial dilutions of an Aspergillus fumigatus strain. Results: Our findings revealed cross-reactivity in five strains using the 50 copies/mL cut-off recommended by the manufacturer, suggesting potential diagnostic errors and inappropriate management of patients. Pre-lysis treatment does not affect the limit of detection at serial dilution. Conclusions: In conclusion, the Aspergillus spp. ELITe MGB Assay exhibits limited specificity in culture-based samples, underscoring the importance of careful utilization in laboratories. Further studies are warranted to better comprehend of the impact of this cross-reactivity on clinical samples.
first_indexed 2024-03-07T19:41:50Z
format Article
id doaj.art-afdb429aa6884cf985ccced219b9e934
institution Directory Open Access Journal
issn 2352-5517
language English
last_indexed 2024-03-07T19:41:50Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Practical Laboratory Medicine
spelling doaj.art-afdb429aa6884cf985ccced219b9e9342024-02-29T05:19:27ZengElsevierPractical Laboratory Medicine2352-55172024-03-0139e00378Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosisViolaine Bothy0Maria A. Argudín1Nathalie Olive2Cindy Barbée3Benoît Kabamba-Mukadi4Hector Rodriguez-Villalobos5Service de microbiologie, Cliniques universitaires Saint-Luc (UCL), Brussels, Belgium; Corresponding author.Service de microbiologie, Cliniques universitaires Saint-Luc (UCL), Brussels, BelgiumService de microbiologie, Cliniques universitaires Saint-Luc (UCL), Brussels, BelgiumService de microbiologie, Cliniques universitaires Saint-Luc (UCL), Brussels, BelgiumService de microbiologie, Cliniques universitaires Saint-Luc (UCL), Brussels, Belgium; Pôle de Recherche en Microbiologie Médicale, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, BelgiumService de microbiologie, Cliniques universitaires Saint-Luc (UCL), Brussels, Belgium; Pôle de Recherche en Microbiologie Médicale, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, BelgiumObjectives: In recent years, commercial molecular tools for diagnosis of invasive aspergillosis have emerged, requiring evaluation to ensure quality. Here we assessed the specificity of Aspergillus spp.-ELITe MGB Assay a commercial assay tergeting 18S gene of Aspergillus spp. Design and methods: As part of a method validation, we evaluate the specificity of the Aspergillus spp.-ELITe MGB Assay by testing fourteen culture based samples of sequenced non-Aspergillus fungal species. The benefits of a pre-lysis treatment was evaluated in parallel on serial dilutions of an Aspergillus fumigatus strain. Results: Our findings revealed cross-reactivity in five strains using the 50 copies/mL cut-off recommended by the manufacturer, suggesting potential diagnostic errors and inappropriate management of patients. Pre-lysis treatment does not affect the limit of detection at serial dilution. Conclusions: In conclusion, the Aspergillus spp. ELITe MGB Assay exhibits limited specificity in culture-based samples, underscoring the importance of careful utilization in laboratories. Further studies are warranted to better comprehend of the impact of this cross-reactivity on clinical samples.http://www.sciencedirect.com/science/article/pii/S2352551724000246AspergillusReal-time PCRElite InGenius
spellingShingle Violaine Bothy
Maria A. Argudín
Nathalie Olive
Cindy Barbée
Benoît Kabamba-Mukadi
Hector Rodriguez-Villalobos
Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis
Practical Laboratory Medicine
Aspergillus
Real-time PCR
Elite InGenius
title Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis
title_full Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis
title_fullStr Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis
title_full_unstemmed Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis
title_short Low specificity of Aspergillus spp. ELITe MGB assay, and potential risks in management of invasive aspergillosis
title_sort low specificity of aspergillus spp elite mgb assay and potential risks in management of invasive aspergillosis
topic Aspergillus
Real-time PCR
Elite InGenius
url http://www.sciencedirect.com/science/article/pii/S2352551724000246
work_keys_str_mv AT violainebothy lowspecificityofaspergillussppelitemgbassayandpotentialrisksinmanagementofinvasiveaspergillosis
AT mariaaargudin lowspecificityofaspergillussppelitemgbassayandpotentialrisksinmanagementofinvasiveaspergillosis
AT nathalieolive lowspecificityofaspergillussppelitemgbassayandpotentialrisksinmanagementofinvasiveaspergillosis
AT cindybarbee lowspecificityofaspergillussppelitemgbassayandpotentialrisksinmanagementofinvasiveaspergillosis
AT benoitkabambamukadi lowspecificityofaspergillussppelitemgbassayandpotentialrisksinmanagementofinvasiveaspergillosis
AT hectorrodriguezvillalobos lowspecificityofaspergillussppelitemgbassayandpotentialrisksinmanagementofinvasiveaspergillosis